Evaluation of a Digital Treatment Tool in Combination With Obesity Medications
The goal of this clinical trial is to evaluate the effect of adding a digi-physical treatment tool as a complement to the local treatment with obesity medication in adolescents with obesity. The main question it aims to answer is: \- Can a combination of a digi-physical treatment tool and obesity medication improve treatment outcomes for patients with obesity compared to patients treated with obesity medications alone? This is a randomized controlled two-arm multicenter study where participants will be randomized to the intervention group (digi-physical treatment+medication) or control group (medication only). Participants will be followed for six months.
• Patients offered liraglutide or semaglutide in accordance with the clinic's routines.
• Aged 12-17 years at the time of inclusion.
• The family agrees to participate in a clinical study.